Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BDNF as a Potential Biomarker for Cognitive Remediation Therapy in Schizophrenia

NCT02341131 is registered in ClinicalTrials.gov with Hospital Clinic of Barcelona as lead sponsor.

NCT NCT02341131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02341131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BDNF as a Potential Biomarker for Cognitive Remediation Therapy in Schizophrenia
Lead sponsor
Hospital Clinic of Barcelona
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
March 31, 2016
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia